GSA Capital Partners’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Buy |
+30,982
| New | +$1.51M | 0.11% | 234 |
|
|
2024
Q3 | – | Sell |
-30,858
| Closed | -$944K | – | 1930 |
|
|
2024
Q2 | $944K | Buy |
30,858
+17,151
| +125% | +$525K | 0.07% | 545 |
|
|
2024
Q1 | $399K | Buy |
+13,707
| New | +$399K | 0.03% | 1039 |
|
|
2022
Q3 | – | Sell |
-11,002
| Closed | -$441K | – | 1797 |
|
|
2022
Q2 | $441K | Sell |
11,002
-13,162
| -54% | -$528K | 0.07% | 575 |
|
|
2022
Q1 | $902K | Buy |
+24,164
| New | +$902K | 0.12% | 217 |
|
|
2021
Q4 | – | Sell |
-17,239
| Closed | -$641K | – | 1723 |
|
|
2021
Q3 | $641K | Buy |
+17,239
| New | +$641K | 0.07% | 541 |
|
|
2021
Q2 | – | Sell |
-8,540
| Closed | -$404K | – | 1546 |
|
|
2021
Q1 | $404K | Buy |
+8,540
| New | +$404K | 0.07% | 465 |
|
|
2020
Q1 | – | Sell |
-5,914
| Closed | -$284K | – | 1454 |
|
|
2019
Q4 | $284K | Buy |
+5,914
| New | +$284K | 0.03% | 1063 |
|
|
2019
Q2 | – | Sell |
-30,832
| Closed | -$1.16M | – | 1678 |
|
|
2019
Q1 | $1.16M | Buy |
30,832
+7,632
| +33% | +$287K | 0.12% | 230 |
|
|
2018
Q4 | $796K | Sell |
23,200
-5,490
| -19% | -$188K | 0.09% | 320 |
|
|
2018
Q3 | $1.35M | Buy |
+28,690
| New | +$1.35M | 0.07% | 483 |
|
|
2017
Q3 | – | Sell |
-24,300
| Closed | -$445K | – | 1841 |
|
|
2017
Q2 | $445K | Buy |
+24,300
| New | +$445K | 0.03% | 1064 |
|
|
2015
Q4 | – | Sell |
-11,487
| Closed | -$307K | – | 1931 |
|
|
2015
Q3 | $307K | Sell |
11,487
-47,787
| -81% | -$1.28M | 0.02% | 1357 |
|
|
2015
Q2 | $2.85M | Buy |
59,274
+35,385
| +148% | +$1.7M | 0.11% | 188 |
|
|
2015
Q1 | $1.45M | Buy |
+23,889
| New | +$1.45M | 0.06% | 572 |
|